Posts by christopher@lifeq.com

Rimidi, LifeQ Partner to Add Wearable-Based Monitoring to Rimidi’s Platform Enabling Early Warning of COVID-19 Infection

August 13th, 2020 Posted by News Story 0 comments on “Rimidi, LifeQ Partner to Add Wearable-Based Monitoring to Rimidi’s Platform Enabling Early Warning of COVID-19 Infection”

With the addition of physiological monitoring via LifeQ’s wearable-based platform, businesses can better predict outbreaks and leverage a critical early warning system for COVID-19 detection in individuals

Rimidi, a cloud-based software platform that enables personalized management of health conditions across populations, today announced a new strategic partnership with LifeQ, a leading provider of biometrics and health information derived from wearable devices.

As a result of the partnership, LifeQ’s physiological data from commercial wrist-worn wearable devices will be integrated into Rimidi’s Epidemic Monitoring Platform, powering a more sensitive and specific screening mechanism for identifying individuals needing further assessment for COVID-19 infection as well as flagging clinical deterioration of COVID-19 cases.

“No single tool in the fight against COVID-19 is sufficient. There is a dire need to identify outbreaks at their onset and early warning systems for detecting COVID-19, especially in asymptomatic or pre-symptomatic individuals, as this is truly the key to controlling spread and predicting new clusters,” said Lucienne Ide, MD, PhD, founder of Rimidi. “Rimidi and LifeQ’s partnership makes this possible. This clinical decision support capability could ultimately replace symptom and exposure self-reporting surveys, and is the future of remote patient monitoring.”

The Rimidi COVID-19 Population Monitoring Toolkit was designed to ensure the health and safety of individuals by offering a holistic platform that combines symptom and exposure surveillance, virus and antibody testing, vaccine and biometric data to give visibility of COVID-19 status across a population of patients or employees. In order to better control the spread of COVID-19, continuous physiological monitoring via wearables, such as smart watches, to predict infection prior to symptom presentation and, ideally, even before viral shedding, is needed. Partnering with LifeQ and adding continuous physiological monitoring via smart watches into the pre-established platform will further assist healthcare providers in identifying high-risk patients, triaging to appropriate testing and tracking complication development.

“By combining Rimidi’s holistic, innovative platform and LifeQ’s in-depth knowledge and understanding of human physiology and systems biology, we are broadening the scope of what’s possible in predicting fundamental physiological processes via wearable devices,” said Laurence Olivier, LifeQ CEO. “With the impact of COVID-19 varying significantly across populations, parallel monitoring of multiple physiological and health features are critical for defining and detecting an accurate enough universal pre-symptomatic COVID-19 biosignature.”

For more information on the partnership or Rimidi’s COVID-19 Monitoring Platform, please visit rimidi.com/lp/employers-covid-19-monitoring-toolkit [rimidi.com/lp/employers-covid-19-monitoring-toolkit __title__ rimidi.com/lp/employers-covid-19-monitoring-toolkit].

About Rimidi
Rimidi is a cloud-based software platform that enables personalized management of health conditions across populations. Created by doctors, Rimidi avoids the disconnect in connected care by combining patient-generated health data with clinical data from the EHR to drive patient-specific clinical insights and actions. The net effect is a better health system with optimized clinical workflows that enable better decisions, better relationships, better outcomes and ultimately a better healthcare system. For more information, visit rimidi.com and follow us on FacebookTwitter and LinkedIn.

About LifeQ
LifeQ is the leading independent provider of biometrics and health information derived from wearable devices, used in world-leading health management solutions. LifeQ’s information and solutions are already used by Fortune 500 customers and partners in a range of wearable devices, consumer-facing health & wellness platforms, and health-risk tracking applications for the global insurance and corporate wellness industries. With offices in South Africa, the USA and Netherlands, LifeQ is ideally placed to globally deliver solutions, leveraging the convergence of new technologies and consumer and business demand for new approaches to health management.

Samsung 1Life Pulse Webinar

July 8th, 2020 Posted by News Story 0 comments on “Samsung 1Life Pulse Webinar”

 

B-Secur partners with LifeQ to bring accurate, combined ECG and PPG sensor biometrics to wearables

July 1st, 2020 Posted by News Story 0 comments on “B-Secur partners with LifeQ to bring accurate, combined ECG and PPG sensor biometrics to wearables”
CATEGORIES Biometrics News  |  Trade Notes  |  Wearable Technology
B-Secur partners with LifeQ to bring high-accuracy heart-rate biometrics and monitoring to wearables

A collaboration to produce superior heartbeat biometric and health monitoring capabilities for wearables has been agreed to by B-Secur and LifeQ.

B-Secur’s Electrocardiogram (EKG/ECG) technology will be integrated with LifeQ’s optical PPG (photoplethysmography) technology to enable advanced identification, wellness and health monitoring features in the next generation of everyday devices, according to the announcement. The companies say in the press release that each is widely recognized for best-in-class performance for their respective technologies.

Many wearables utilize PPG for blood flow monitoring, and LifeQ provides PPG signal conditioning to leading consumer technology companies for higher accuracy in business and clinical applications. B-Secur says advances in ECG technology can enable high-accuracy biosensing in future product releases.

“Many of the technology features that are on offer through an integrated B-Secur and LifeQ solution are currently only accessible in medical environments or by the fortunate few. Today’s announcement will accelerate access of this type of information to everyone. We are very fortunate to find a partner in LifeQ that shares a common goal and we are confident that together we provide class-beating technologies,” states Alan Foreman, CEO of B-Secur.

The collaboration is expected to speed up the integration, launch and adoption of high-performance biosensing solutions OEMs for secure health and wellness features in smartwatches and other fitness trackers.

“With technology advancement and the increasing quest to improve health and wellbeing, whether to consumers, employees, employers, and even governments, the global biosensing market has grown exponentially in recent years,” says Laurie Olivier, CEO of LifeQ. “Events such as COVID-19 have further highlighted the importance of real time health monitoring and, specifically to make this available to everyone. We are thrilled that our partnership with B-Secur allows us to accelerate our goal of improving wellbeing and reducing the cost of good health for all in conjunction with some of the world’s leading technology companies.”

VeoSens launched by 1Life in South Africa

June 11th, 2020 Posted by Press Release 0 comments on “VeoSens launched by 1Life in South Africa”

11 June 2020 – Stellenbosch, South Africa: LifeQ announced today the first commercial launch of VeoSens – a wearable-based, fully integrated insurance and health management solution developed in partnership with Samsung and Hannover Re.

1Life, a leading direct life insurer in South Africa, is launching a world-first life insurance ecosystem – 1Life Pulse, utilising VeoSens. The aim is to bring life insurance, technology and science together in a simple way, providing consumers with attainable, dynamic, long-term value for making better choices regarding their wellbeing.

All new qualifying 1Life policy holders that take out cover for R1 million or more can choose to receieve a Samsung Galaxy Watch Active 2, chipped against their 1Life policy number. As soon as customers take up cover they earn an immediate R50 000 towards their life cover. From there, each time the watch is strapped on, all data collected contributes towards additional cover that can grow by up to R200 000 over two years.

“Our offering is underpinned by the fact that, as your life and health changes, so too does your cover,” says 1Life CEO, Laurence Hillman. “This is a world-first and we are excited at the prospect of what this will mean for the consumer and their capacity to make better choices around their wellbeing.”

LifeQ, Hannover Re and Samsung have worked together for over two years to create the VeoSens solution, providing insurers with a unique Consumer Engagement, Digital Data Collection and Innovation Platform. Working in close partnership with our insurance customers, the goal is for VeoSens to change the way the life and health insurance industries operate, leveraging new technology to create whole new models for insurance.

VeoSens utilises LifeQ’s solutions, which are based on computational systems biology; modelling the body’s physiological systems and how they interact with each other. LifeQ enabled solutions fill the gap between medical devices and basic consumer devices, providing business grade health information to enable real health and risk management.

 “At Samsung, we are always looking for strategic partnerships that not only bolster the Galaxy ecosystem but, more importantly, deliver an unrivalled user experience coupled with exceptional consumer benefits. This partnership does exactly this – enabling us to demonstrate our vision of a connected lifestyle,” says Kagiso Khaole, Head of Content and Services at Samsung South Africa.

LifeQ contributes three key components to these solutions: Software to enable wearable devices to continuously and accurately track key biometrics and compile this into a format that can be stored for further analysis; Sophisticated cloud based models that generate a wide range of of health information and insights, and; A highly secure data platform to enable all partners to work seamlessly together while fully protecting and de-identifying consumer data, meeting all relevant global standards.

“VeoSens is a great example of how LifeQ combines life sciences and technology to bring novel life changing solutions to the market with clear economic benefits to both businesses and consumers,” says Laurie Olivier, LifeQ CEO. “ Without information that is more accurate than generated on the average wearable, and forward looking business leaders that are willing to embrace state of the art technologies, this would not have been possible – we want to thank Samsung, Hannover Re and 1Life for being great partners towards setting a new bar in the life insurance industry.” 

LifeQ

LifeQ is the leading independent provider of biometrics and health information derived from wearable devices, used in world-leading health management solutions. LifeQ’s information and solutions are already used by Fortune 500 customers and partners in a range of wearable devices, consumer-facing health & wellness platforms, and health-risk tracking applications for the global insurance and corporate wellness industries. Backed by a range of institutional and family office investors, with offices in South Africa, the USA and Holland, LifeQ is a company ideally placed to deliver solutions, leveraging the convergence of new technologies and consumer and business demand for new approaches to health management.

 

*1Life Pulse is an optional benefit at an additional cost, subject to specified qualifying criteria.

1Life, Samsung and LifeQ Launch “Life Insurance Ecosystem”

June 11th, 2020 Posted by News Story 0 comments on “1Life, Samsung and LifeQ Launch “Life Insurance Ecosystem””

1Life, Samsung South Africa and LifeQ have partnered to launch life insurance ecosystem, 1Life Pulse. This initiative is backed by wearables and app technology and enables consumers to grow their life insurance cover by “making better choices”.

1Life Pulse acts as a lifestyle monitor and management system that tracks and guides heart, activity and sleep – monitoring overall wellbeing. Every time a consumer chooses to get a little extra sleep or go for a walk, for example, they’re likely to grow their life cover by up to R216 per day, or up to R6 560 per month, starting from day one.

Over two years, policyholders are able to grow their additional life cover by up to R200 000, as they grow their wellbeing.

All qualifying new 1Life policyholders that take out cover for R1 million or more, receive a Samsung Galaxy Watch Active 2, chipped against their 1Life policy number. By simply downloading and activating the VeoSens App by Samsung and LifeQ, consumers can start growing their life insurance.

“We can’t all be athletes or go to the gym, especially now with social distancing –  but we can all do the activities of ‘life’ well and this is what the 1Life Pulse product and ecosystem encourages,” says Laurence Hillman, CEO of 1Life.

“We want to help ordinary South Africans on a journey of positive change, helping them make better choices around their wellbeing and to be rewarded through real-time increases to their life insurance every month.”

“Our offering is underpinned by the fact that, as your life and wellbeing grows, so too does your cover. This is a new way of life cover, which we believe will be the way of life cover in the future,” concludes Hillman.